Click here to see a list of our past events.
There are no results that match that selection.
As data-driven innovation accelerates, healthcare stakeholders still struggle with a central question: How do we quantify the value of the data we hold? Even with unprecedented volumes of clinical and operational data, valuation methods remain fragmented and inconsistent. Providers, entrepreneurs and investors often approach data with very different priorities and expectations. Persistent challenges include gaps between perceived and realizable data value, difficulty comparing heterogeneous datasets, and increasing legal and regulatory constraints.
This session will examine how hospitals, digital health innovators, medtech companies and investors are defining and benchmarking data value in real-world transactions. The panel will also explore recommendations for strong data-sharing agreements and how expectations for rigorous, auditable valuation models are evolving.
RSVP here.
Panelists include:
- Roger Cohen, Partner, Goodwin Procter (Moderator)
- Greg Banker, Partner, Vensana Capital
- Chris David, Founder & Managing Partner, HealthValue Group
- Natasha Hunerlach, Partner, EY/Parthenon
- Stefan Vilsmeier, Founder, President & CEO, Brainlab
*This program is being organized by BioVenture eLab of Weill Cornell Medicine Enterprise Innovation with Wendy Diller, founder of LifeScInnovation and author of “Data is the New Gold: Quantifying Its Value To Medtech Presents Challenges,” published in the October 2025 issue of Medtech Strategist.
Center for Technology Licensing (CTL) at Weill Cornell Medicine Office Hours with Eric Bryant are held every other month and open to all who wish to get answers to their intellectual property questions and gain more information about the advancement of their IP filings with a one-on-one meeting.
Eric holds a Master of Science in Biomedical Engineering from New York University, a Juris Doctor from New York Law School, and is a registered patent attorney. He works with the Weill Cornell office to execute on intellectual property strategy, review submitted invention disclosures, and manage domestic and foreign patent filings and patent prosecution.
Eric’s expertise encompasses a variety of technologies including, but not limited to, diagnostics tools and methods, pharmaceuticals, controlled release therapeutic devices, respiratory devices, surgical tools, biological technologies and nanotechnology.
To reserve your private, 30-minute Zoom session with Eric, click here.
Could your innovative research change the world? Participate in a free, month-long course to receive expert guidance as you evaluate the market potential of your deep technology innovation. You’ll gain a deeper understanding of your industry and learn valuable professional skills in the process. These virtual and conference-based courses are led by the Interior Northeast I-Corps Hub.
The following conference course begins online and features funded customer discovery travel to an industry-specific event:
- February 13 – March 18: Open to researchers developing digital health innovations. Features travel to Las Vegas, NV for the HIMSS Global Health Conference & Exhibition. Hosted in partnership with University at Buffalo & University of Vermont. Apply by January 21.
The following virtual courses are open to innovators in all STEM fields:
- January 16 – February 19: Hosted in partnership with Binghamton University. Apply by December 10.
- February 2 – March 4: Hosted in partnership with University of Pittsburgh. Apply by January 7.
- February 23 – March 25: Open to startup/incubator teams. Hosted in partnership with Syracuse University. Apply by January 28.
- March 9 – April 8: Hosted in partnership with Dartmouth College. Apply by February 11.
Applications will be reviewed on a rolling basis. Apply now! Please contact icorps@cornell.edu for any questions.
Are you a researcher looking to make an impact through innovation? Explore technology commercialization through Introduction to Entrepreneurship for Ph.D.s and Postdocs, a program that empowers researchers to bring innovations to market and overcome the challenges of leading a technology-based business.
This program combines a proven entrepreneurship curriculum with a focus on leadership development and empowerment. Content will be delivered at two full-day, on-campus (in Ithaca) weekend workshops in Spring 2026:
- Workshop 1 in January will focus on fostering entrepreneurial skills and community-building with the cohort
- Workshop 2 in February will focus on fundraising, operations, and next steps
Participants will finish the program equipped to take the next steps in their entrepreneurship journeys. All students at Cornell conducting research at the graduate level and higher are welcome to apply by November 20, 2025.
Contact the program team by emailing crea@cornell.edu.
Join Kirk Macolini, President of InteliSpark, LLC, for this virtual workshop providing insights into the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) application process. During the workshop, Macolini will discuss and answer questions regarding writing and submitting a successful SBIR/STTR proposal and identifying strategies for making your SBIR/STTR proposal more competitive.
Upon registering, participants will receive access to the SBIR/STTR video series, a set of short videos containing valuable background information, which they are encouraged to view prior to the workshop. The pre-workshop video series covers:
- An overview of the SBIR/STTR programs
- Program eligibility requirements
- Differences between SBIR and STTR agencies
- Using SBIR/STTR to enhance your company's value
Register here. Questions? Contact sbirassistance@cornell.edu.
The Dean’s Office and Enterprise Innovation invite you to an afternoon filled with insightful discussions on biomedical innovation and entrepreneurship and a celebration of Weill Cornell’s innovator-entrepreneurs.
This symposium features:
- A fireside chat with Dean Robert A. Harrington and Barry Kappel, Ph.D. ’06, M.B.A., Founder, President, CEO & Director of Sapience Therapeutics
- Faculty and industry presentations and panel on innovation and aging
- Presentation on developing a novel DBS treatment for traumatic brain injury by Nicholas Schiff, M.D. ’92, Professor of Neuroscience
- One-on-one office hours with business development and licensing experts
- Introduction of EI Catalyst Fund
- A networking reception
RSVP here.
Entrepreneurship at Cornell hosts the Eclectic Convergence summit annually in New York City featuring speakers who are inspiring, entrepreneurial role models. Don’t miss your chance to listen to amazing speakers, network with fellow Cornellians, students and business executives, and watch some of Cornell’s awesome startups pitch their businesses.
During the networking breaks, you will have a chance to meet and mingle with approximately 450 enthusiastic attendees including faculty and alumni – many of whom are active entrepreneurs, venture capitalists and angel investors.
RSVP here.
Join us for a dynamic panel exploring the critical role of prototyping in medical device development. Whether you're navigating early-stage innovation or scaling within a global enterprise, this session offers valuable perspectives.
Moderated by Dr. Donna Rounds, associate director of business development and licensing at the Center for Technology Licensing, panelists include:
- Audrey Beckman – seasoned executive with 35+ years of experience in leadership roles in medical device product design
- Anthony Carnemolla – serial entrepreneur and medical device CEO
- Dr. Mohammed Fouda – neurosurgeon innovating in pediatric device development
- Dr. Rache Simmons – breast surgeon and key opinion leader focused on patient-centered design
Center for Technology Licensing (CTL) at Weill Cornell Medicine Office Hours are open to all who wish to gain more information about the advancement of their patent filings and to discuss their technology venture project in a one-on-one meeting with a business development and licensing professional. The October office hours will be hosted by Brian Kelly, Ph.D., CLP, director of business development and licensing.
Brian manages a portfolio of inventions focusing on oncology, gene therapy, metabolic diseases, the microbiome and endocrine disorders. Prior to joining CTL at Weill Cornell, he served as director of intellectual property for New York University’s tech transfer office. He has also held positions at the University of Minnesota as a licensing associate, Heide, Hyde & O’Donnell as an associate European patent attorney and Smith, Kline & French as a research chemist.
Register here for your 30-minute private session.
